Ticker
NAOVCompany Name
NANOVIBRONIX INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 4.06M | 0.62 | $ 6.54M |
3/31/2025 | $ 601K | 0.07 | $ 8.2M |
12/31/2024 | $ 752K | 0.28 | $ 2.72M |
9/30/2024 | $ 1.3M | 0.52 | $ 2.52M |
6/30/2024 | $ 2.17M | 0.85 | $ 2.56M |
3/31/2024 | $ 2.7M | 1.11 | $ 2.43M |
12/31/2023 | $ 3.28M | 1.34 | $ 2.45M |
9/30/2023 | $ 3.79M | 1.58 | $ 2.39M |
6/30/2023 | $ 253K | 0.11 | $ 2.37M |
3/31/2023 | $ 1.51M | 0.66 | $ 2.29M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for NANOVIBRONIX INC is calculated as follows: CashnEq [ $ 3.53M ] / LiabilitesC [ $ 364K ]
(=) Cash Ratio [ 9.7 ]
Minimum
Mar 31, 2025
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |